Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.
Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. Goyal G, et al. Among authors: shah mv. Haematologica. 2020 Jan 31;105(2):348-357. doi: 10.3324/haematol.2019.219626. Print 2020. Haematologica. 2020. PMID: 31004029 Free PMC article.
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.
Bubik RJ, Barth DM, Hook C, Wolf RC, Muth JM, Mara K, Patnaik MS, Pruthi RK, Marshall AL, Litzow MR, Elliott MA, Hogan WJ, Shah MV, Begna KH, Alkhateeb H, Pardanani A, Ashrani AA, Call TG, Rivera CE, Camoriano JK, Go RS, Wolanskyj-Spinner AP, Parikh SA. Bubik RJ, et al. Among authors: shah mv. Leuk Lymphoma. 2020 Jul;61(7):1592-1600. doi: 10.1080/10428194.2020.1737684. Epub 2020 Mar 11. Leuk Lymphoma. 2020. PMID: 32157935
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF, Kenderian SS, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Hampel PJ, et al. Among authors: shah mv. Blood Cancer J. 2021 Mar 2;11(3):47. doi: 10.1038/s41408-021-00443-1. Blood Cancer J. 2021. PMID: 33654067 Free PMC article. No abstract available.
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.
Li M, Binder M, Lasho T, Ferrer A, Gangat N, Al-Kali A, Mangaonkar A, Elliott M, Litzow M, Hogan W, Pardanani A, Wolanskyj-Spinner A, Howard M, King RL, Shah M, Alkhateeb H, Begna K, Tefferi A, Finke C, Oliveira J, Ketterling R, Olteanu H, Patnaik MM. Li M, et al. Blood Adv. 2021 Apr 27;5(8):2272-2278. doi: 10.1182/bloodadvances.2020003976. Blood Adv. 2021. PMID: 33904893 Free PMC article. No abstract available.
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.
Nanaa A, Viswanatha D, Xie Z, Jevremovic D, Nguyen P, Salama ME, Greipp P, Bessonen K, Gangat N, Patnaik M, Pardanani A, Alkhateeb HB, Shah M, Hogan W, Tefferi A, Litzow M, He R, Al-Kali A. Nanaa A, et al. Blood Cancer J. 2021 Jun 30;11(6):122. doi: 10.1038/s41408-021-00517-0. Blood Cancer J. 2021. PMID: 34193836 Free PMC article. No abstract available.
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.
Alkhateeb HB, Nanaa A, Viswanatha D, Foran JM, Badar T, Sproat L, He R, Nguyen P, Jevremovic D, Salama ME, Greipp P, Gangat N, Tefferi A, Litzow MR, Mangaonkar AA, Shah MV, Patnaik M, Al-Kali A. Alkhateeb HB, et al. Among authors: shah mv. Blood Adv. 2022 Jan 25;6(2):528-532. doi: 10.1182/bloodadvances.2021005738. Blood Adv. 2022. PMID: 34644397 Free PMC article.
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
Salama Y, Zhao F, Oliveira JL, Yuan J, Jevremovic D, Go RS, Ding W, Parikh SA, Shah MV, Hampel PJ, Al-Kali A, Morice WG, Shi M. Salama Y, et al. Among authors: shah mv. Blood Cancer J. 2022 Feb 22;12(2):30. doi: 10.1038/s41408-022-00632-6. Blood Cancer J. 2022. PMID: 35194022 Free PMC article.
244 results